Skip to main content
Top
Published in: Dermatology and Therapy 6/2021

Open Access 01-12-2021 | Lymphoma | Review

A Comprehensive Update of the Atypical, Rare and Mimicking Presentations of Mycosis Fungoides

Authors: Eve Lebas, Patrick Collins, Joan Somja, Arjen F. Nikkels

Published in: Dermatology and Therapy | Issue 6/2021

Login to get access

Abstract

Introduction

Mycosis fungoides (MF) is the most frequent subtype of primary cutaneous T cell lymphomas (pCTCL). The diagnosis may be particularly difficult in the early stages as well as in atypical and rare clinical presentations. Furthermore, MF may simulate a large variety of common dermatologic disorders and patterns, both histopathologically and clinically.

Methods

A literature search was performed to provide a comprehensive update on the rare and atypical MF manifestations as well as the dermatoses and dermatological patterns that could be imitated by MF.

Results

A total of 114 publications were found describing a series of different dermatoses and dermatological patterns mimicked by MF, as well as some particular localizations of MF lesions and dermatoses that occur in preexisting MF lesions.

Conclusions

The number of dermatoses that can be imitated by MF is ever-increasing. Patients with common dermatologic conditions that prove to be treatment refractory should be biopsied without delay, and sequentially as necessary, to prevent delay in diagnosis and progression of disease. Clinicopathologic correlation is the best way of diagnosis.
Literature
1.
go back to reference Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70:205.CrossRef Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70:205.CrossRef
8.
go back to reference Vaidya T, Badri T. Mycosis fungoides. In: StatPearls. Treasure Island: StatPearls Publishing; 2020. (PMID: 30137856). Vaidya T, Badri T. Mycosis fungoides. In: StatPearls. Treasure Island: StatPearls Publishing; 2020. (PMID: 30137856).
17.
go back to reference Seßkin D. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014. Ital Dermatol Venereol. 2014;149:401–8. Seßkin D. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014. Ital Dermatol Venereol. 2014;149:401–8.
18.
go back to reference Nikkels AF, Quatresooz P, Delvenne P, Balsat A, Piérard GE. Mycosis fungoides progression and chronic solvent exposure. Dermatology. 2004;208:171–3.CrossRefPubMed Nikkels AF, Quatresooz P, Delvenne P, Balsat A, Piérard GE. Mycosis fungoides progression and chronic solvent exposure. Dermatology. 2004;208:171–3.CrossRefPubMed
28.
go back to reference Venturini A, Zane C, Rodella R, Leali C, Calzavara Pinton P, Zorzi F. Syringotropic cutaneous T cell lymphoma treated with PUVA therapy. Eur J Dermatol. 2005;15:262–4.PubMed Venturini A, Zane C, Rodella R, Leali C, Calzavara Pinton P, Zorzi F. Syringotropic cutaneous T cell lymphoma treated with PUVA therapy. Eur J Dermatol. 2005;15:262–4.PubMed
30.
go back to reference Soyer HP, Smolle J, Kerl H. Dyshidrotic mycosis fungoides. J Cutan Pathol. 1987;14:372. Soyer HP, Smolle J, Kerl H. Dyshidrotic mycosis fungoides. J Cutan Pathol. 1987;14:372.
36.
go back to reference Krebs A, Zala A, Graber W, Meyer A, Jenni C. Mycosis fungoides. Dermatologica. 1978;157:312–5. Krebs A, Zala A, Graber W, Meyer A, Jenni C. Mycosis fungoides. Dermatologica. 1978;157:312–5.
52.
go back to reference Whitmore SE, Simmons-O’Brien E, Rotter FS. Hypopigmented mycosis fungoides. Dermatology. 1994;130:476–80. Whitmore SE, Simmons-O’Brien E, Rotter FS. Hypopigmented mycosis fungoides. Dermatology. 1994;130:476–80.
53.
go back to reference Lin TL, Chen YJ, Wen YC, Yang CS, Juan CK. Pityriasis lichenoid-like mycosis fungoides in a 9-year-old boy: a case report. Acta Dermatovenerol Croat. 2019;27:37–9.PubMed Lin TL, Chen YJ, Wen YC, Yang CS, Juan CK. Pityriasis lichenoid-like mycosis fungoides in a 9-year-old boy: a case report. Acta Dermatovenerol Croat. 2019;27:37–9.PubMed
55.
go back to reference Vaudreuil AM, Stroud CM, Hsu S. Psoriasis mimicking mycosis fungoides clinically. Dermatol Online J. 2017;23:13030/qt3r4942kh.PubMed Vaudreuil AM, Stroud CM, Hsu S. Psoriasis mimicking mycosis fungoides clinically. Dermatol Online J. 2017;23:13030/qt3r4942kh.PubMed
56.
go back to reference Azizpour A, Ghanadan A, Nasimi M, Etesami I. Psoriasiform mycosis fungoides: a rare form of the disease with review of the literature. Dermatol Online J. 2017;23:13030/qt9mv8r0j7.PubMed Azizpour A, Ghanadan A, Nasimi M, Etesami I. Psoriasiform mycosis fungoides: a rare form of the disease with review of the literature. Dermatol Online J. 2017;23:13030/qt9mv8r0j7.PubMed
70.
go back to reference Radeff B, Mérot Y, Saurat JH. Acquired epidermal cysts and mycosis fungoids. A possible pitfall in clinical staging. Am J Dermatopathol. 1988;10:424–9.PubMed Radeff B, Mérot Y, Saurat JH. Acquired epidermal cysts and mycosis fungoids. A possible pitfall in clinical staging. Am J Dermatopathol. 1988;10:424–9.PubMed
73.
go back to reference Lacour JP, Castanet J, Perrin C, Ortonne JP. Follicular mycosis fungoids. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases. J Am Acad Dermatol. 1993;29:330–4.CrossRefPubMed Lacour JP, Castanet J, Perrin C, Ortonne JP. Follicular mycosis fungoids. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases. J Am Acad Dermatol. 1993;29:330–4.CrossRefPubMed
86.
go back to reference Badawy E, D’Incan M, El Majjaoui S, et al. Ichthyosiform mycosis fungoides. Eur J Dermatol. 2002;12:594–6.PubMed Badawy E, D’Incan M, El Majjaoui S, et al. Ichthyosiform mycosis fungoides. Eur J Dermatol. 2002;12:594–6.PubMed
98.
go back to reference Camisa C, Aulisio A. Pustular mycosis fungoides. Cutis. 1994;54:202–4.PubMed Camisa C, Aulisio A. Pustular mycosis fungoides. Cutis. 1994;54:202–4.PubMed
116.
go back to reference Lebas E, Quatresooz P, Arrese JE, Nikkels AF. Eruptive seborrheic keratoses restricted to plaque/patch-stage mycosis fungoides. Case Rep Dermatol. 2017;9:35–9.CrossRefPubMedPubMedCentral Lebas E, Quatresooz P, Arrese JE, Nikkels AF. Eruptive seborrheic keratoses restricted to plaque/patch-stage mycosis fungoides. Case Rep Dermatol. 2017;9:35–9.CrossRefPubMedPubMedCentral
117.
go back to reference Lebas E, Arrese JE, Nikkels AF. Risk factors for skin infections in mycosis fungoides. Dermatology. 2016;232:731–7.CrossRefPubMed Lebas E, Arrese JE, Nikkels AF. Risk factors for skin infections in mycosis fungoides. Dermatology. 2016;232:731–7.CrossRefPubMed
129.
134.
go back to reference Ahmad A, Semkova K, Stefanato CM, Calonje EJ, Choczaj-Kukula A, Palamaras I. Tiger-like mycosis fungoides: an unusual clinical presentation of a rare variant of mycosis fungoides. Dermatol Online J. 2019;25:13030/qt0w1035f7.PubMed Ahmad A, Semkova K, Stefanato CM, Calonje EJ, Choczaj-Kukula A, Palamaras I. Tiger-like mycosis fungoides: an unusual clinical presentation of a rare variant of mycosis fungoides. Dermatol Online J. 2019;25:13030/qt0w1035f7.PubMed
Metadata
Title
A Comprehensive Update of the Atypical, Rare and Mimicking Presentations of Mycosis Fungoides
Authors
Eve Lebas
Patrick Collins
Joan Somja
Arjen F. Nikkels
Publication date
01-12-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 6/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00625-6

Other articles of this Issue 6/2021

Dermatology and Therapy 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.